Skip to main content

Scientists unwind mystery behind DNA replication

A new perspective from Cornell physicists is helping unravel the mystery of how DNA’s double helix manages to replicate.

Innovation flourishes across Cornell’s campuses

Cornell’s New York City campuses also have embraced and encouraged new technology, directions and platforms to increase engagement and boost research and real-world connections.


Superhero program calms children in preparation for MRIs

Turning an MRI exam into a superhero adventure helps prepare children for the test and reduces the need for sedation, according to research by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

Weill Cornell hosts medical student mental health conference

The first National Conference on Medical Student Mental Health and Well-Being, hosted by Weill Cornell Medicine, put a spotlight on the increasing rates of psychological distress among medical students.

Scientists retrace monarch’s toxin-immunity evolution

By editing specialized genes into laboratory fruit flies, scientists have reconstructed evolution and instantly conferred in the flies the same toxin resistance enjoyed by monarch butterflies.

New metabolic discovery may inform heart disease, diabetes solutions

Science may be inching closer to thwarting obesity, heart disease and Type 2 diabetes, as Cornell biochemists have uncovered a key step in how the human body metabolizes sugar.

Symposium bridges cancer research across Cornell

The second annual Intercampus Cancer Symposium, Oct. 11 at the Cornell College of Veterinary Medicine, will highlight the wide range of cancer research taking place at Cornell’s Ithaca campus and at Weill Cornell Medicine in New York City.

Precision Nutrition Symposium to foster intercampus research

Cornell will host a Precision Nutrition Symposium, Oct. 14-15, designed to foster the development of collaborative and multidisciplinary working groups from Cornell’s Ithaca and New York City campuses.

Staff News

NIH grants food scientists $2.6M to battle bacteria

The NIH has awarded Cornell a $2.6 million grant to study bacteriophages – microscopic foot soldiers in the fight against pathogenic bacteria.